Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Otsuka joins forces with IBM for Watson-based digital venture

Otsuka Digital Health will develop software to analyse psychiatric patient data

IBM Watson health pharma
IBM's Watson-based cognitive computing product for oncology (PRNewsFoto/IBM)

Otsuka and IBM have formed a digital health company in Japan that will develop and market specialist software to analyse psychiatric patient data.  

Known as Otsuka Digital Health, the partners' joint venture will formally established on Friday, with the pharma company taking an 85% stake in it to IBM Japan's 15%.  

The company has been set up to market MENTAT, software whose development was based on Otsuka's knowledge of central nervous system disorders and IBM's Watson-based technology.  

In a statement Otsuka said: “In psychiatry, patient symptoms and medical history are not usually enumerated and are entered into non-standardised electronic medical charts.  

“Therefore it takes significant time and effort for hospital medical staff to analyse and understand a large volume of records, and a massive of amount data is not used well.”  

The company hopes that its new digital health company and MENTAT software will enable hospital medical staff to use electronic medical records with more insight and, ultimate, provide better patient care.  

The venture will operate independently of Otsuka's pharmaceutical business, where its CNS interests, where it is one of the five-biggest companies in the world, thanks to products such as Abilify.

15th June 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics